A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC Academic Article uri icon

Overview

MeSH Major

  • Lung Neoplasms
  • Molecular Targeted Therapy
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Small Cell Lung Carcinoma
  • Xenograft Model Antitumor Assays

abstract

  • Fractional decrease in FDG SULmax from baseline to post-cycle 1 imaging was significantly different between anatomic responders and non-responders, while percentage changes in FLT SULmax were not significantly different between these groups over the same period of time.

publication date

  • December 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5247390

Digital Object Identifier (DOI)

  • 10.1186/s13550-017-0258-3

PubMed ID

  • 28102506

Additional Document Info

start page

  • 8

volume

  • 7

number

  • 1